Filter your results
- 4
- 4
- 4
- 1
- 1
- 1
- 1
- 4
- 4
- 3
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 4
- 4
- 3
- 3
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Removal of the calpain 3 protease reverses the myopathology in a mouse model for titinopathiesHuman Molecular Genetics, 2010, 19 (23), pp.4608-4624. ⟨10.1093/hmg/ddq388⟩
Journal articles
hal-02321460v1
|
||
|
CAPN3-mediated processing of C-terminal titin replaced by pathological cleavage in titinopathyHuman Molecular Genetics, 2015, 24 (13), pp.3718-3731. ⟨10.1093/hmg/ddv116⟩
Journal articles
hal-02336889v1
|
||
|
234th ENMC International Workshop: Chaperone dysfunction in muscle disease Naarden, The Netherlands, 8–10 December 2017Neuromuscular Disorders, 2018, 28 (12), pp.1022-1030. ⟨10.1016/j.nmd.2018.09.004⟩
Journal articles
hal-02332981v1
|
||
Atypical phenotypes in titinopathies explained by second titin mutationsAnnals of Neurology, 2014, 75 (2), pp.230-240. ⟨10.1002/ana.24102⟩
Journal articles
istex
hal-02336903v1
|